International Journal of Medical and Pharmaceutical Research
2020, Volume-1, Issue-1 doi: 10.5281/zenodo.7694343
Original Article
Growth Performance And Economic Impact Of Broilerchicken Fed Concentrates Supplemented With Processed Cocoa Pod Waste
Abstract
The study was conducted to examine the performance growth and economic impacts of broiler chicken fed concentrates supplemented with processed cocoa pod waste. The experiment was conducted at the Teaching and Research Farm, University of Uyo, Uyo, Akwa Ibom State. Cocoa pod waste or husk was collected and processed by ash treatment to form a processed cocoa pod husk meal (PCHM). Three experimental diets were formulated at both the starter and finisher phases, in which PCHM was included at 0, 5 and 10% and designated as diets 1, 2 and 3, respectively. One hundred and eighty 1-day-old Arbor Acres broiler chicks were randomly distributed to three dietary treatments (10 birds/replicate; 60 birds/treatment) in a completely randomized design. The growth performance, carcass, relative internal organ weights and haemato biochemical indices were determined. Histological examination of the liver and heart samples was also determined. Results: The PCHM inclusion did affect (P < 0.05) the performance characteristics of the broiler chicks and also for the feed intake that significantly (P < 0.05) increased in birds fed 8% of PCHM-inclusive diet at the starter phase. The carcass traits, relative internal organ weights, haematological indices and serum biochemical indices of the broiler chickens were similar (P > 0.05) across the dietary treatments. The serum glutathione peroxidase and catalase concentration were higher (P < 0.05) in birds fed PCHM-inclusive diets compared to those fed the control diet. Implications and recommendations were made from the findings of the study.
Recommended Articles
Loading Image...
Volume-1, Issue-1
Citations
2004 Views
255 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved